» Articles » PMID: 10080

Behavior of Transaldolase (EC 2.2.1.2) and Transketolase (EC 2.2.1.1) Activities in Normal, Neoplastic, Differentiating, and Regenerating Liver

Overview
Journal Cancer Res
Specialty Oncology
Date 1976 Sep 1
PMID 10080
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this investigation was to throw light on the biological behavior and metabolic regulation of hepatic enzymes of the nonoxidative branch of the pentose phosphate pathway. The activities of transaldolase (EC 2.2.1.2) and trasketolase (EC 2.2.1.1) Were compared in biological conditions that involve modulation of gene expression such as in starvation, in differentiation, after partial hepatectomy, and in a spectrum of hepatomas of different growth rates. The enzyme activities were determined under optimal kinetic conditions by spectrophotometric methods in the 100,000 X g supernatant fluids prepared from tissue homogenates. The kinetic properties of transaldolase and transketolase were similar in normal liver and in rapidly growing hepatoma 3924A. For transaldolase, apparent Km values of 0.13 mM (normal liver) and 0.17 mM (hepatoma) were observed for erythrose 4-phosphate and of 0.30 to 0.35 mM for fructose 6-phosphate. The pH optima in liver and hepatoma were at approximately 6.9 to 7.2. For the transketolase substrates, ribose 5-phosphate and xylulose 5-phosphate, the apparent Km values were 0.3 and 0.5 mM, respectively, in both liver and hepatoma. A broad pH optimum around 7.6 was observed in both tissues. In organ distribution studies, enzyme activities were measured in liver, intestinal mucosa, thymus, kidney, spleen, brain, adipose tissue, lung, heart, and skeletal muscle. Taking the specific activity of liver as 100%, transaldolase activity was the highest in intestinal mucosa (316%) and in thymus (219%); it was the lowest in heart (53%) and in skeletal muscle (21%). Transketolase activity was highest in kidney (155%) and lowest in heart (26%) and skeletal muscle (23%). Starvation decreased transaldolase and transketolase activities in 6 days to 69 and 74%, respectively, of those of the liver of the normal, fed rat. This was in the same range as the decrease in the protein concentration (66%y. In the liver tumors, transaldolase activity was increased 1.5- to 3.4-fold over the activities observed in normal control rat liver. Transketolase activity showed no relationship to tumor proliferation rate. In the regenerating liver at 24 hr after partial hepatectomy, the activity of both pentose phosphate pathway enzymes was in the same range as that of the sham-operated controls. In differentiation at the postnatal age of 5, 12, 23, and 32 days, hepatic transaldolase activities were 33, 44, 55, and 72%, respectively, of the activities observed in the 60-day-old, adult male rat. During the same period, transketolase activ-ties were 18, 21, 26, and 55% of the activities observed in liver of adult rat. The demonstration of increased transaldolase activity in hepatomas, irrespective of the degree of tumor malignancy, differentiation, or growth rate, suggests that the reprogramming of gene expression in malignant transformation is linked with an increase in the expression of this pentose phosphate pathway enzyme...

Citing Articles

Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation.

Zheng Z, Xiao P, Kuang J, Wang Z, Wang X, Huang D J Cancer. 2025; 16(3):821-834.

PMID: 39781339 PMC: 11705062. DOI: 10.7150/jca.105849.


Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer.

Xu G, Huang R, Wumaier R, Lyu J, Huang M, Zhang Y Cancer Res. 2024; 84(19):3267-3285.

PMID: 38900939 PMC: 11443238. DOI: 10.1158/0008-5472.CAN-23-3998.


Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma.

Bhat S, Farooq Z, Ismail H, Corona-Avila I, Khan M Technol Cancer Res Treat. 2023; 22:15330338231219434.

PMID: 38083797 PMC: 10718058. DOI: 10.1177/15330338231219434.


Ribose Intake as Food Integrator: Is It a Really Convenient Practice?.

Moschini R, Balestri F, Cappiello M, Signore G, Mura U, Del-Corso A Biomolecules. 2022; 12(12).

PMID: 36551203 PMC: 9776227. DOI: 10.3390/biom12121775.


Enzymatic Depletion of Mitochondrial Inorganic Polyphosphate (polyP) Increases the Generation of Reactive Oxygen Species (ROS) and the Activity of the Pentose Phosphate Pathway (PPP) in Mammalian Cells.

Hambardikar V, Guitart-Mampel M, Scoma E, Urquiza P, Nagana G, Raftery D Antioxidants (Basel). 2022; 11(4).

PMID: 35453370 PMC: 9029763. DOI: 10.3390/antiox11040685.